Randomised Study of High-dose Epirubicin Versus High-dose Epirubicin-Cisplatin Chemotherapy for Advanced Soft Tissue Sarcoma

By Jelic S.   Kovcin V.   Milanovic N.   Babovic N.   Kreacic M.   Ristovic Z.   Vlajic M.   Filipovic-Ljeskovic I.  

European Journal of Cancer, Vol. 33, Iss. 2, 1997-02 ,pp. : 220-225

Elsevier

Access to resources Recommend Favorite

Docetaxel and high-dose epirubicin as neoadjuvant chemotherapy in locally advanced breast cancer

By Espinosa E.   Morales S.   Borrega P.   Casas A.   Madroñal C.   Machengs I.   Illarramendi J.   Lizón J.   Moreno J.   Belón J.   Janáriz J.   Puente M.   Checa T.   Mel J.   González Barón M.  

Cancer Chemotherapy and Pharmacology, Vol. 54, Iss. 6, 2004-12 ,pp. : 546-552

Springer Publishing Company

Access to resources Recommend Favorite

High-dose Carboplatin and Etoposide for Salvage Chemotherapy of Germ Cell Tumours

By Dearnaley D.P.   Lampe H.   Price A.   Mehta J.   Powles R.   Nicholls J.   Horwich A.  

European Journal of Cancer, Vol. 31, Iss. 5, 1995-01 ,pp. : 717-723

Elsevier

Access to resources Recommend Favorite

A limited role for VEEP (vincristine, etoposide, epirubicin, prednisolone) chemotherapy in childhood Hodgkin's disease

By Shankar A.G.   Ashley S.   Atra A.   Kingston J.E.   Mott M.   Pinkerton C.R.  

European Journal of Cancer, Vol. 34, Iss. 13, 1998-12 ,pp. : 2058-2063

Elsevier

Access to resources Recommend Favorite

Considerable Plasma Levels of a Cytotoxic Etoposide Metabolite in Patients Undergoing High-dose Chemotherapy

By Stremetzne S.   Jaehde U.   Kasper R.   Beyer J.   Siegert W.   Schunack W.  

European Journal of Cancer, Vol. 33, Iss. 6, 1997-05 ,pp. : 978-979

Elsevier

Access to resources Recommend Favorite